Endpoints News 生物医药· Ryan Cross·· 8 天前AI 评分15
Ira Mellman 对 Parker Institute 的癌症免疫疗法感到失望
Ira Mellman wants Parker Institute to restore cancer immunotherapy
AI 导读
Ira Mellman 对 Revolution Medicines 的新抗癌药物 daraxonrasib 表示失望,尽管全球对此药反响热烈。
正文
While the whole world was applauding Revolution Medicines’ new cancer drug, all Ira Mellman felt was disappointment and frustration.
The pill, daraxonrasib, kept patients with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news